ADMET |
Absortion, Distribution, Metabolism, Excretion and Toxicity |
AML |
Acute Myeloid Leukemia |
AMP |
Antimicrobial Peptide |
BTC |
Bicycle Toxin Conjugate |
CME |
Clathrin-Mediated Endocytosis |
CPP |
Cell-Penetrating Peptide |
cCPP |
Cationic Cell-Penetrating Peptide |
CvME |
Caveolae-Mediated Endocytosis |
DPV |
Diatos Peptide Vector |
ELP |
Elastin-Like Polypeptide |
EN1 |
Engrailed 1 |
ER+ |
Estrogen Receptor-Positive |
FRET |
Fluorescence Resonance Energy Transfer |
GAG |
Glycosaminoglican |
GEP-NET |
Gastroenteropancreatic Neuroendocrine Tumor |
GPCR |
G Protein-Coupled Receptor |
HS |
Heparan Sulfate |
HTH |
Helix-turn-helix |
iPep |
Interfering Peptide |
MAP |
Model Amphipathic Peptide |
MDR |
Multidrug Resistance |
MMP |
Matrix Metalloproteinase |
MT1-MMP |
Membrane Type 1 Matrix Metalloproteinase |
NET |
Neuroendocrine Tumor |
OSCC |
Oral Squamous Cell Carcinoma |
PAR1 |
Protease-Activated Receptor 1 |
PCNA |
Proliferating Cell Nuclear Antigen |
PDX |
Patient-Derived Xenograft |
PGE2 |
Prostaglandin E2 |
PNA |
Peptide Nucleic Acid |
PP2A |
Protein Phosphatase 2A |
PRRT |
Peptide Receptor Radionuclide Therapy |
PS |
Phosphatidylserine |
ROS |
Reactive Oxygen Species |
saCPP |
Secondary Amphipathic Cell-Penetrating Peptide |
SAR |
Structure-Activity Relationship |
SSTR2 |
Type 2 Somatostatin Receptor |
TAM |
Tumor-Associated Macrophage |
TNBC |
Triple-Negative Breast Cancer |
WT |
Wild-Type |